David Hou

912 total citations
13 papers, 536 citations indexed

About

David Hou is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, David Hou has authored 13 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in David Hou's work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune cells in cancer (4 papers). David Hou is often cited by papers focused on CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (6 papers) and Immune cells in cancer (4 papers). David Hou collaborates with scholars based in United States, Mexico and China. David Hou's co-authors include Catalina Lee-Chang, Maciej S. Lesniak, Brandyn Castro, Aida Rashidi, Peng Zhang, Jason Miska, Ting Xiao, Yu Han, Craig Horbinski and Aurora Lopez‐Rosas and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

David Hou

12 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Hou United States 8 277 264 167 127 77 13 536
Brian M. Andersen United States 10 240 0.9× 127 0.5× 116 0.7× 119 0.9× 31 0.4× 10 385
Natalia Di Ianni Italy 12 160 0.6× 261 1.0× 200 1.2× 126 1.0× 85 1.1× 15 533
James Ross United States 12 214 0.8× 140 0.5× 184 1.1× 174 1.4× 91 1.2× 24 559
Magdalena Kijewska Poland 7 198 0.7× 141 0.5× 195 1.2× 154 1.2× 107 1.4× 9 470
Antonela S. Asad Argentina 12 140 0.5× 129 0.5× 216 1.3× 125 1.0× 65 0.8× 20 451
Ryan Bash United States 13 129 0.5× 126 0.5× 187 1.1× 183 1.4× 120 1.6× 25 517
Luqing Tong China 12 177 0.6× 169 0.6× 237 1.4× 125 1.0× 141 1.8× 24 516
Diane D. Mao United States 11 102 0.4× 150 0.6× 242 1.4× 128 1.0× 104 1.4× 16 482
Hikmat Assi United States 12 367 1.3× 251 1.0× 294 1.8× 136 1.1× 69 0.9× 17 763
Zhengdao Lan United States 5 233 0.8× 176 0.7× 311 1.9× 127 1.0× 135 1.8× 5 632

Countries citing papers authored by David Hou

Since Specialization
Citations

This map shows the geographic impact of David Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hou more than expected).

Fields of papers citing papers by David Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hou. The network helps show where David Hou may publish in the future.

Co-authorship network of co-authors of David Hou

This figure shows the co-authorship network connecting the top 25 collaborators of David Hou. A scholar is included among the top collaborators of David Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Hou. David Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Arrieta, Víctor A., Jasim Kada Benotmane, Junfei Zhao, et al.. (2024). Characterization of Immune Cell Heterogeneity, Key B Cell Subtypes, and Macrophages Functions Using Multiplex Immunofluorescence and Single-cell RNA Sequencing in Chordomas. Neurosurgery. 70(Supplement_1). 202–203.
2.
Hou, David, et al.. (2023). Generation of B-cell-based cellular vaccine for cancer in murine models. STAR Protocols. 4(2). 102219–102219. 1 indexed citations
3.
Teng, Kun‐Yu, Anthony G. Mansour, Zheng Zhu, et al.. (2022). Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer. Gastroenterology. 162(4). 1319–1333. 95 indexed citations
4.
Miska, Jason, Aida Rashidi, Catalina Lee-Chang, et al.. (2021). Polyamines drive myeloid cell survival by buffering intracellular pH to promote immunosuppression in glioblastoma. Science Advances. 7(8). 75 indexed citations
5.
Hou, David, Brandyn Castro, Aida Rashidi, et al.. (2021). IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8+ MEMORY T CELLS. Neuro-Oncology. 23(Supplement_6). vi100–vi100. 1 indexed citations
6.
Castro, Brandyn, et al.. (2021). Current Immunotherapeutic Strategies for the Treatment of Glioblastoma. Cancers. 13(18). 4548–4548. 16 indexed citations
7.
Hou, David, et al.. (2021). The Interplay between Glioblastoma and Its Microenvironment. Cells. 10(9). 2257–2257. 89 indexed citations
8.
Hou, David, Brandyn Castro, Aida Rashidi, et al.. (2021). EXTH-29. DUAL TGFB AND PD1 BLOCKADE PROMOTES GERMINAL-CENTER B-CELL IMMUNE RESPONSES AGAINST GLIOBLASTOMA. Neuro-Oncology. 23(Supplement_6). vi169–vi169. 2 indexed citations
9.
Lee-Chang, Catalina, Jason Miska, David Hou, et al.. (2020). Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma. The Journal of Experimental Medicine. 218(1). 49 indexed citations
10.
Lee-Chang, Catalina, Jason Miska, David Hou, et al.. (2020). 167 B-cell-based vaccination elicit potent immunity against glioblastoma. SHILAP Revista de lepidopterología. A99.2–A101. 1 indexed citations
11.
Lee-Chang, Catalina, Aida Rashidi, Jason Miska, et al.. (2019). Myeloid-Derived Suppressive Cells Promote B cell–Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma. Cancer Immunology Research. 7(12). 1928–1943. 120 indexed citations
12.
Hang, Dong, et al.. (2012). Prognostic value of the stem cell markers CD133 and ABCG2 expression in esophageal squamous cell carcinoma. Diseases of the Esophagus. 25(7). 638–644. 61 indexed citations
13.
Zeng, Xiankun, Shree Ram Singh, David Hou, & Steven X. Hou. (2010). Tumor suppressors Sav/scrib and oncogene ras regulate stem‐cell transformation in adult Drosophila malpighian tubules. Journal of Cellular Physiology. 224(3). 766–774. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brian M. Andersen Breakdown of academic impact, for papers by Natalia Di Ianni Breakdown of academic impact, for papers by James Ross Breakdown of academic impact, for papers by Magdalena Kijewska Breakdown of academic impact, for papers by Antonela S. Asad Breakdown of academic impact, for papers by Ryan Bash Breakdown of academic impact, for papers by Luqing Tong Breakdown of academic impact, for papers by Diane D. Mao Breakdown of academic impact, for papers by Hikmat Assi Breakdown of academic impact, for papers by Zhengdao Lan
Rankless by CCL
2026